Dashboard
Manage Tickers

IMNNImunon, Inc.

Nasdaq imunon.com


$ 1.14 $ 0.06 (5.56 %)    

Tuesday, 17-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.83 $ -2.14 (-0.45 %)
DIA $ 417.12 $ -0.26 (-0.06 %)
SPY $ 563.14 $ 0.30 (0.05 %)
TLT $ 100.82 $ -0.51 (-0.5 %)
GLD $ 237.35 $ -1.31 (-0.55 %)
$ 1.14
$ 1.11
$ 1.13 x 203
$ 1.15 x 400
$ 1.11 - $ 1.14
$ 0.48 - $ 3.65
291,402
na
16.42M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-19-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-25-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-11-2018 03-31-2018 10-Q
27 03-27-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-24-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-12-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

imunons-ovarian-cancer-rd-day-on-september-18-2024-to-feature-presentations-from-imnn-001-clinical-study-investigators-immunology-and-biostatistics-experts-and-executive-management
IMUNON's Ovarian Cancer R&D Day On Septemb...
09/09/2024 12:48:45

September 18th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to Tr...

hc-wainwright--co-reiterates-buy-on-imunon-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Imun...
08/15/2024 11:25:37

HC Wainwright & Co. analyst Emily Bodnar reiterates Imunon (NASDAQ:IMNN) with a Buy and maintains $14 price target.

imunon-q2-eps-051-beats-060-estimate
Imunon Q2 EPS $(0.51) Beats $(0.60) Estimate
08/14/2024 12:05:00

Imunon (NASDAQ:IMNN) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.60) by 15 ...

imunon-q2-2024-gaap-eps-051-beats-060-estimate-cash-investments-and-accrued-interest-receivable-of-53m-as-of-june-30-2024-combined-with-net-proceeds-of-approximately-9m-from-registered-direct-offering-capital-resources-are-expected-to-be-sufficient-to-fund-its-operations-into-q3-2025
Imunon Q2 2024 GAAP EPS $(0.51) Beats $(0....
08/14/2024 12:04:20

peering-into-imunons-recent-short-interest
Peering Into Imunon's Recent Short Interest
08/05/2024 19:45:13

hc-wainwright--co-maintains-buy-on-imunon-raises-price-target-to-14
HC Wainwright & Co. Maintains Buy on Imuno...
08/05/2024 10:47:22

HC Wainwright & Co. analyst Emily Bodnar maintains Imunon (NASDAQ:IMNN) with a Buy and raises the price target from $12 ...

why-imunon-imnn-stock-is-down-60-today
Why Imunon (IMNN) Stock Is Down 60% Today
07/31/2024 19:32:08

Imunon shares are trading lower by 61% during Wednesday's session. The company announced a $10 million registered direct of...

nasdaq-surges-over-3-powell-industries-shares-spike-higher
Nasdaq Surges Over 3%; Powell Industries S...
07/31/2024 19:02:17

dow-jumps-over-200-points-kraft-heinz-shares-gain-after-q2-earnings
Dow Jumps Over 200 Points; Kraft Heinz Sha...
07/31/2024 16:45:07

imunon-announces-10m-registered-direct-offering-of-5m-shares-of-common-stock-with-unregistered-warrants-at-a-price-of-2unit
IMUNON Announces $10M Registered Direct Of...
07/31/2024 12:15:10

IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today annou...

nasdaq-down-1-jetblue-airways-shares-spike-higher
Nasdaq Down 1%; JetBlue Airways Shares Spi...
07/30/2024 18:31:01

why-merck-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Merck Shares Are Trading Lower By 10%?...
07/30/2024 17:53:26

nano-cap-imunons-lead-candidate-shows-overall-survival-of-around-11-months-in-untreated-ovarian-cancer-patients
Nano-Cap IMUNON's Lead Candidate Shows Ove...
07/30/2024 17:07:40

IMUNON shares surge on Tuesday with 105.5 million volume following positive Phase 2 OVATION 2 Study results for IMNN-001 in adv...

crude-oil-down-1-procter--gamble-shares-fall-after-q4-results
Crude Oil Down 1%; Procter & Gamble Shares...
07/30/2024 16:16:27

dow-jumps-200-points-pfizer-earnings-top-views
Dow Jumps 200 Points; Pfizer Earnings Top ...
07/30/2024 14:12:54

imunon-announces-announces-topline-results-from-phase-2-ovation-2-study-with-imnn-001-results-showed-111-month-in-median-overall-survival-vs-standard-of-care-alone-in-intent-to-treat-population
IMUNON Announces Announces Topline Results...
07/30/2024 12:06:37

Core News & Articles
Market-Moving News for July 30th
07/30/2024 11:56:59

PYPL: 7% | PayPal Holdings Q2 2024 Adj EPS $1.19 Beats $0.98 Estimate, Sales $7.90B Beat $7.81B Estimate SFM: 18% | Sprouts Far...

why-f5-shares-are-trading-higher-by-over-14-here-are-20-stocks-moving-premarket
Why F5 Shares Are Trading Higher By Over 1...
07/30/2024 09:50:34

Core News & Articles
CORRECTION: Imunon Ticker Is "IMNN"
07/29/2024 20:31:47

imunon-to-report-topline-results-from-the-phase-2-ovation-2-study-with-imnn-001-in-advanced-ovarian-cancer-july-30-at-800-am-et
IMUNON To Report Topline Results From The ...
07/29/2024 20:25:10

Results to be announced at 8:00 a.m. Eastern time, conference call to begin at 8:30 a.m. Eastern time

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION